In our annual panel at the AVBCC Annual Summit, Capitol Street joined leading oncology clinicians, analysts, and payer experts to explore critical issues shaping the future of cancer care, including:

• The state of frontline oncology practice and how payer dynamics impact access to treatment
• Breakthroughs in new therapies, from CAR-T and gene therapies to bispecifics, and what is driving (or slowing) adoption
• How policy developments such as Medicare drug negotiation, MFN proposals, and CMMI models are reshaping the oncology landscape
• Perspectives from payers and Wall Street on drug pricing, value-based care, and the evolving cancer care ecosystem